Abstract
Clostridioides difficile is the most common cause of antibiotic-associated diarrhoea globally. Its spores have been implicated in the prevalence of C. difficile infection due to their resistance and transmission ability between surfaces. Currently, disinfectants such as chlorine-releasing agents (CRAs) and hydrogen peroxide are used to decontaminate and reduce the incidence of infections in clinical environments. Our previous research demonstrated the ability of C. difficile spores to survive exposure to recommended concentrations of sodium dichloroisocyanurate in liquid form and within personal protective fabrics such as surgical gowns; however, the present study examined the spore response to clinical in-use concentrations of sodium hypochlorite. Spores were exposed to a 10 min contact time of 1000, 5000 and 10 000 p.p.m. sodium hypochlorite, and spore recovery was determined. To understand whether biocide-exposed spores transmitted across clinical surfaces in vitro, biocide-exposed spores were spiked onto surgical scrubs and patient gowns and recovery was determined by a plate transfer assay. Scanning electron microscopy was used to establish if there were any morphological changes to the outer spore coat. The results revealed that viable biocide-exposed C. difficile spores can be recovered from surgical scrubs and patient gowns, with no observable changes to spore morphology, highlighting the potential of these fabrics as vectors of spore transmission. This study demonstrates that alternative strategies should be urgently sought to disinfect C. difficile spores to break the chain of transmission in clinical environments.
Keywords: biocide, disinfectant, tolerance, spores, Clostridioides difficile, transmission
Introduction
Clostridioides difficile is a Gram-positive, anaerobic, spore-forming bacterium and the primary aetiological agent of antibiotic-associated diarrhoea globally [1]. Exposure to antibiotics has been shown to disrupt the colonic microbiota of the gut which permits C. difficile colonization in 4 % of adults and 15–70 % of infants [2]. Therefore, the spectrum of C. difficile infection (CDI) varies from asymptomatic carriage, mild or severe diarrhoea to life-threatening pseudomembraneous colitis, toxic megacolon and death [3, 4]. CDI causes ~29 000 deaths per year in the USA and 8382 deaths per year in Europe, with current data showing that the incidence of CDI was increasing prior to the start of the COVID-19 pandemic in the UK [5, 6]. While the cause of increased CDI during this period is currently a source of debate, these data confirm that C. difficile is still very much present within healthcare environments.
Patients with CDI are usually treated with antibiotics such as metronidazole, vancomycin and fidaxomicin [7]. Recent studies, however, have established antibiotic resistance within C. difficile ; concerningly, plasmid-mediated metronidazole resistance (pMETRO plasmid) has been found and fluoroquinolone-resistant C. difficile has been found to be directly associated with metronidazole resistance [8, 9]. Currently research into vancomycin resistance is being explored, and recently in vivo resistance to fidaxomicin has been described [10, 11]. The implications of antibiotic resistance in C. difficile are significant and include increased infection incidence, mortality and transmission of C. difficile . Another factor affecting C. difficile spore transmission is the recurrence and reinfection rates in CDI patients [12]. Recurrent CDI (rCDI) occurs after successful antibiotic treatment of CDI where there is either relapse of infection by the same C. difficile strain, or reinfection by another strain. The percentage likelihood of rCDI increases significantly after the first episode, with the second recurrence rate at 40 % and subsequent recurrences at 45–65 % [12]. This highlights the urgent need for updated and effective infection control procedures to break the chain of transmission of C. difficile .
C. difficile produces highly resistant spores with CDI patients able to excrete 104–107 spores per gram of faeces into the environment [13]. Transmission of C. difficile occurs primarily in healthcare environments via the faecal–oral route by direct contact with the infected person or by indirect contact with a contaminated source, and once ingested, its spores enter the colon and germinate [1, 4, 14–16]. C. difficile spores are highly resistant to biocide disinfectants, desiccation, nutrient depletion, UV light and radiation, meaning they can survive in hostile environments for months [15–17]. Moreover, spores of C. difficile spores have been found to be continually transmitted via shoes, surfaces and personal protective equipment (PPE) leading to the continued spread of this infection [18].
Chlorine-releasing agents (CRAs) are used in the disinfection of fluid spills, blood and faeces [19]. Current UK guidelines recommend use of CRAs at 1000 p.p.m. for ~10 min contact time to disinfect surfaces soiled with C. difficile ; CRAs are a low-cost, efficient disinfection method used in healthcare facilities to disinfect surfaces and include sodium hypochlorite bleach (NaOCl) and sodium dichloroisocyanurate (NaDCC) [19–21]. However, recent studies have shown emerging sporicidal resistance to 1000 p.p.m. NaDCC [21, 22]. The growing evidence of C. difficile spore resistance to disinfection with CRAs poses important questions about how to disinfect clinical environments effectively [23]. The mechanisms of CRA action on C. difficile spores are poorly understood and current disinfection paradigms are based on studies using Bacillus spores [24–28].
In this study, we examined the sporicidal efficacy of sodium hypochlorite disinfectant on C. difficile spore survival because we have already conducted similar studies using only NaDCC [21, 22]. We also assessed the transfer ability of C. difficile spores from PPE pre- and post-biocide exposure using a plate transfer assay. The PPE tested included surgical scrubs and patient hospital gowns and the presence of spores within fabrics was determined using scanning electron microscopy. This study aimed to increase understanding of the efficacy of NaOCl as a disinfectant and whether direct disinfection of PPE fabrics could potentially limit spore transmission.
Methods
Growth conditions, C. difficile ribotypes and spore production
C. difficile strains from two clinically relevant ribotypes (RTs) were used in this study: the hypervirulent epidemic Stoke-Mandeville R20291 strain (RT 027), clinical isolate DS1813 (RT 027) and the type strain CD630 (RT012). These strains have been widely tested for susceptibility to disinfection [20, 29, 30]. Strains used in this study and their PCR RTs are described in Table 1 and were obtained from the Anaerobic Reference Unit, University Hospital Wales, Cardiff, UK. C. difficile cultures from the two RTs were incubated at 37 °C for 48 h in an anaerobic workstation (Don Whitley Scientific) using 85 % nitrogen, 10 % carbon dioxide and 5 % hydrogen gas. Unless otherwise stated, all organisms were stored as spores at 4 °C. All experiments were repeated three times (n=3) at room temperature (22 °C).
Table 1.
C. difficile strains used in the present study [29]
C. difficile strain |
PCR ribotype |
Source |
---|---|---|
027 |
Stoke-Mandeville |
|
DS1813 |
027 |
Hinchingbrooke |
CD630 |
012 |
NCTC |
Spores were purified using a previously described method [31, 31]. Briefly, C. difficile spores were cultured on reduced Brain Heart Infusion (BHI) agar supplemented with 0.5 % yeast extract, 0.1 % l-cysteine and 0.1 % sodium taurocholate and were examined after 4 days of anaerobic incubation for characteristic colonies. Spores were harvested from the agar plates using Sterile Deionized Water (SDW) and density gradient-washing where spores were centrifugated three times with SDW for 5 min at 10 000 g and then treated with 50 % HistoDenz (Sigma-Aldrich). Spores were then washed with SDW and stored at 4 °C. Spore purity was confirmed via phase contrast microscopy. Spore concentration was determined via drop count as described by Miles et al. [32] and mean colony-forming units (c.f.u.) per ml were calculated [33].
Exposure of spores to sodium hypochlorite disinfectant
Spores from strains R20291, DS1813 and CD630 (Table 1) at a concentration of 1×108 spores ml–1 were independently exposed to 1000, 5000 and 10 000 p.p.m. NaOCl in liquid form for 10 min (recommended contact time) and biocide activity was neutralized with an equal volume of 5 g l–1 sodium thiosulphate for 10 min contact time to remove any residual chlorine biocide activity [20, 28, 29]. Spores were enumerated on supplemented BHI agar after anaerobic incubation at 37 °C for 48 h and growth of a single C. difficile colony on the agar correlated to evidence of single spore germination [31, 32]. NaOCl (14 % active chlorine; Merck) was diluted to the correct concentration (in p.p.m.) using SDW. For the spore transfer tests to surgical scrubs and patient gowns, the spores were then directly deposited onto each sterile fabric surface and tested via a plate transfer assay (described below). Control experiments where spores were exposed to sodium thiosulphate, sterile deionized water and NaOCl alone were also performed.
Preparation of PPE fabric surfaces
Multi-use surgical scrubs and patient gowns, worn in UK hospital departments, were ordered from MediSave. Surgical scrubs (order no. VSCRUB) made from 65 % polyester and 35 % cotton, and patient gowns (order no. PG221) made from polycotton were used. To test the transfer of spores to and from the surgical scrubs and patient gowns, the fabrics were aseptically cut into 7×7 cm sections and testing was performed within a drawn circle of 2 cm diameter to conform with the surface area of a 100 g weight which was used to simulate ‘touch’ pressure in this study [22, 33].
Spore transfer to surgical scrubs and to patient gowns
To determine whether the PPE used in this study was hydrophobic (water repellent) or hydrophilic (attracted to water), and could potentially act as fomites, the surgical scrubs and patient gowns were directly tested with spores in SDW. Spores from strains CD630, DS1813 and R20291 (Table 1) were produced at 1×109 spores ml–1 and 100 µl of each was spiked onto each fabric surface and remained in static contact for 10 min before being removed and discarded. If hydrophobic, the liquid would sit on the fabric as a droplet, but if hydrophilic, the time taken for the fabric to absorb all the liquid was recorded. After contact with spores, each section of fabric was aseptically mounted onto a plunger pre-affixed with a 100 g circular weight (to mimic ‘touch pressure’ force) so that the weight was aligned with the test area. An agar plate transfer test was then performed as previously described in Joshi et al. [33]. All agar plates were then incubated for 48 h at 37 °C under anaerobic conditions. Following incubation, C. difficile colonies were counted and colonies (c.f.u. ml–1) were calculated.
Scanning electron microscopy
Scanning electron microscopy (SEM) was used to determine the presence of characteristic spores before and after treatment with NaOCl. Spores which had not been exposed to NaOCl were used as a comparative control. Samples were fixed with 2.5 % glutaraldehyde and were transferred onto Nucleopore membranes (Sigma-Aldrich) which were sputter coated with gold palladium (60 % Au and 40 % Pd; Testbourne) and argon was used as the sputtering gas. An accelerating voltage of 15 kV was used to view 30 individual spores per sample at ×12 000 magnification (JEOL JSM-6610 Series SEM).
Statistical analysis
Data are expressed as means±sem. Student t-tests and Kruskal–Wallis tests were performed using Minitab 19 (Minitab), where P<0.05 was considered statistically significant.
Results
C. difficile spores show tolerance to working concentrations of sodium hypochlorite disinfectant
Three clinically relevant strains of C. difficile were exposed to in-use working concentrations of sodium hypochlorite (NaOCl) disinfectant at concentrations of 1000, 5000 and 10 000 p.p.m. and biocide activity was neutralized after 10 min contact time. Spores were tested at a concentration of 1×108 c.f.u. ml−1. The reduction in spore germination was measured and compared to controls (strains which were not exposed to NaOCl), and spore viability was determined. The results are shown in Fig. 1. Spores from each of the three strains tested showed tolerance to treatment with sodium hypochlorite disinfectant with spore recovery ranging between 1 and 6.5×107 c.f.u. ml−1 across all ribotypes. This is a reduction of approximately 1log10 (Student’s t-test, P<0.05).
Fig. 1.
Recovery of purified C. difficile spores following exposure to NaOCl at 1000, 5000 and 10 000 p.p.m. in liquid for 10 min. The spore inoculum was at 108 c.f.u. ml−1. The inoculum was used as the positive control (water only) and was also suspended in sodium thiosulphate to ensure no cross-reactivity. Plots represent means±sem (n=3).
Strain R20291 (027) showed an increase in spore recovery following exposure to 10 000 p.p.m. compared to R20291 spores exposed to 1000 and 5000 p.p.m. respectively; however, this was deemed to be non-significant (Kruskal–Wallis, P=0.1017). Strain DS1813 (027) showed a 1log10 reduction in spores after treatment with NaOCl, with the most effective concentration being 10 000 p.p.m. when compared to the control (Student’s t-test, P<0.05). The same is true of CD360 (012) which showed a similar reduction in spore recovery response when exposed to sodium hypochlorite at 10 000 p.p.m. (Student’s t-test, P=0.0360). Interestingly, CD630 spore recovery was slightly higher when treated with 5000 p.p.m. NaOCl compared to CD630 spores treated with 1000 p.p.m.; however, this was not significant (Student’s t-test, P<0.05).
SEM was used to visually analyse the surface architecture of C. difficile spores before and after 10 000 p.p.m. NaOCl exposure (Fig. 2). SEM studies confirmed the presence of intact spores before treatment; non-treated spores of CD630, DS1813 and R20291 display characteristic oval-shaped spores with a smooth outer surface morphology and evidence of an exosporium (Fig. 2a, c, e) [19, 29]. No visible damage to the spore outer architecture can be seen for any of the strains tested with NaOCl; the post-treatment images show similar morphology to non-treated spores (Fig. 2b, d, f). This supports previous data that spores can tolerate biocide exposure and remain viable.
Fig. 2.
Scanning electron microscopy of C. difficile R20291, CD1813 and CD630 spores before and after liquid exposure with 10 000 p.p.m. NaOCl. (a) Non-exposed C. difficile R20291, (b) C. difficile R20291 exposed to 10 000 p.p.m. NaOCl, (c) non-exposed C. difficile DS1813, (d) C. difficile DS1813 exposed to 10 000 p.p.m. NaOCl, (e) non-exposed C. difficile CD630 and (f) C. difficile CD630 exposed to 10 000 p.p.m. NaOCl. Bars, 1 µm in all images. No spore damage is visible following NaOCl exposure. Spores above were imaged at ×12 000 magnification.
Spores adhere to surgical scrubs and patient gowns
To determine if scrubs and gowns can act as fomites in clinical settings, purified C. difficile R20291, DS1813 and CD630 spores were applied at a concentration of 1×108 c.f.u. ml−1 to these fabrics for 10 min (Fig. 3). Both fabrics were hydrophilic; surgical scrubs took 30–40 s to absorb the solution while patient gowns took 3 min. In Fig. 3, fewer C. difficile spores appear to be recovered from the gowns compared to the scrubs; however, this was not statistically significant, meaning similar amounts of spores adhered and were retained across both fabrics (Kruskal–Wallis, P=0.0947). There was also no significant difference in adherence between the strain of C. difficile used and the recovery of spores for both scrubs and gowns (Kruskal–Wallis, P>0.05).
Fig. 3.
Transmission of purified C. difficile spores from spiked surgical scrubs and patient gowns. C. difficile spores from strains R20291, DS1813 and CD630 at 1×108 c.f.u. ml−1 were inoculated onto the fabrics for a 10 min contact time with each fabric surface. Spores were then recovered via a plate transfer assay. Plots represent mean±sem (n=3).
Spore transfer to surgical scrubs and patient gowns following exposure to sodium hypochlorite disinfectant
Previously, spore survival was determined in liquid (Fig. 1) following treatment with NaOCl. To determine whether spores transferred after exposure to biocide, C. difficile spores were inoculated onto surgical scrubs and treated with NaOCl (Fig. 4). C. difficile R20291 spore recovery from scrubs decreases after exposure to 1000, 5000 and 10 000 p.p.m. NaOCl compared to non-exposed R20291 spores, indicating they are retained on the fabric with no significant difference between strains and biocide concentration (Student’s t-test, P>0.05). C. difficile DS1813 spores demonstrate no significant reduction in spore recovery following treatment with 1000, 5000 and 10 000 p.p.m. NaOCl (Kruskal–Wallis, P>0.05). In Fig. 4, a clear reduction in C. difficile CD630 spore recovery is displayed after 1000 and 5000 p.p.m. NaOCl treatment compared to non-exposed CD630 spores, but this was not significant (Kruskal–Wallis, P>0.05). A 1log10 reduction in CD630 spore recovery is seen between non-exposed and 10 000 p.p.m. NaOCl-treated but no statistical significance was determined (Student’s t-test, P=0.0777).
Fig. 4.
Recovery of purified C. difficile R20291, DS1813 and CD630 spores from spiked surgical scrubs following exposure of 108 c.f.u. ml−1 to NaOCl at 1000, 5000 and 10 000 p.p.m. for 10 min. Spores not exposed to NaOCl (water only) were used as a positive control and the use of NaOCl only was used as a negative control, where no spores were recovered. Plots represent mean±sem (n=3).
C. difficile spore recovery was then determined from patient gowns (Fig. 5). An approximate 1log10 reduction in R20291 spore recovery was observed between non-exposed and NaOCl-exposed R20291 spores, although no significant difference in spore recovery was identified, indicating spores remained adhered to the gowns (Kruskal–Wallis, P>0.05). In Fig. 5, it appears there is an increase in R20291 spore recovery following 10 000 p.p.m. NaOCl exposure compared to R20291 spores exposed to 5000 p.p.m. NaOCl but no significant difference was found (Student’s t-test, P=0.3168). DS1813 spore survival seems to decrease as NaOCl concentration increases, but no significance was detected (Kruskal–Wallis, P>0.05). A 1log10 reduction was detected between non-exposed CD630 spores and CD630 spores exposed to all NaOCl concentrations (Student’s t-test, P<0.05).
Fig. 5.
Recovery of purified C. difficile R20291, DS1813 and CD630 spores from spiked patient gowns following exposure of 108 c.f.u. ml−1 to NaOCl at 1000, 5000 and 10 000 p.p.m. for 10 min. Spores not exposed to NaOCl (water only) were used as a positive control and the use of NaOCl only was used as a negative control, where no spores were recovered. Plots represent mean±sem (n=3).
Discussion
Management of CDI in healthcare settings relies on effective infection control measures to reduce the spread of C. difficile spores [34]. This study explored the efficacy of NaOCl for disinfection of C. difficile spores in liquid, and on clinically relevant fabrics including surgical scrubs and patient gowns. Currently, the National Health Services use a working concentration of 1000–5000 p.p.m. of chlorine for 10 min for spore decontamination on surfaces [19]. However, in this study 1000 p.p.m. NaOCl only reduced C. difficile R20291 spore recovery in liquid compared to the other strains tested (Figs 1, 3 and 4). Interestingly, the hypervirulent R20291 and DS1813 (RT027) strains (Table 1) have been suggested to be more resistant to CRAs compared to other ribotypes [20, 22, 29, 30] supporting our data. When spores were treated with 10 000 p.p.m. NaOCl in liquid there was low log reduction, but the literature indicates that the most effective disinfectants yield a log reduction of between 3 and >5 log units generally [30, 35, 36]. Previous biocide contact studies have found similar results when exploring C. difficile spore killing with CRAs [29, 30, 37].
Most hospital-acquired infections are transmitted through the hands of healthcare workers and by direct contact with fomites [18]. Consequently, scrubs and gowns are worn in hospitals as PPE to reduce the transmission of infectious material and break the chain of transmission. Previously, we showed that surgical single-use gown ties, when worn inappropriately, can act as fomites and contribute to transmission of C. difficile in clinical environments [18]. This present study highlights that both surgical scrubs and patient gowns can act as fomites as they attracted and retained C. difficile spores which could then be transferred to a hydrophilic surface (Figs 3–5). This supports the results from similar studies, where fabrics and surgical scrubs retained Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus bacteria [38, 39].
Differences in the physiochemical properties of scrubs and gowns have been shown to play a critical role in the dissemination of microorganisms through hospitals [37, 40]. The limited variation in R20291, DS1813 and CD630 spore recovery from these fabrics may be due to spore hydrophobicity; these strains have hydrophobicity values of 62, 77 and 63 %, respectively [33]. Fewer C. difficile spores were recovered from the fabrics (Fig. 3) than liquid (Fig. 1), suggesting spores may survive better within the fabrics by adhering to specific fibres. This adherence result correlates with our previous studies that tested NaDCC on clinically relevant fabrics, showing more spores remained on the fabric fibres, and hence the ability of the spores to transfer over to the hydrophilic agar plate was reduced [21, 22]. The strains of spores tested in this study were also resistant to NaOCl decontamination directly on the surgical scrubs, indicating these spores can remain viable, adhere to and subsequently transfer onto different clinical surfaces. Similarly, the survival of spores on these fabrics after exposure to NaOCl suggests that the biocide may not have penetrated the PPE effectively to interact directly with the spores. This is useful in some respect given that PPE is designed to be hydrophobic; however, in the case of our study, we have already shown that these fabrics attract spores within liquid [22]. This emphasizes the need to use appropriate disinfection measures when disinfecting PPE such as surgical scrubs and patient gowns [18].
In this study, SEM was used to determine whether CRA use physically damaged the outer spore layers. The results clearly demonstrated no visible effect on spore morphology after biocide exposure, which correlates with results from our previous study [20]. C. difficile spores characteristically possess an exosporium layer that is closely associated with spore adherence to organic and inorganic surfaces. Damage to the outer exosporium layer and spore coat has been hypothesized to change the adherence and transmissibility of spores [33]. In this study, the lack of damage to the C. difficile spores highlights increased tolerance of clinically relevant spores to disinfection with CRAs, and their increased adherence ability to clinical fabrics after biocide exposure (Figs 3–5). These results suggest that CRA use within clinical settings should be evaluated to ensure that efficaeous disinfection methods are employed to reduce the potential for spore transmission and CDI. Indeed, more NHS trusts are using alternative means of disinfection such as hydrogen peroxide fogging and UV-C treatment to effectively manage CDI [41–43]. It is noted, however, that in low- to middle-income countries (LMICs) the use of cheaper and accessible biocides such as CRA are essential in infection control [44]. The impact of CRA tolerance in microorganisms within LMIC healthcare settings has yet to be elucidated but understanding biocide tolerance within these settings could be an important factor in manging the emergence of antimicrobial-resistant bacteria.
Effective management of CDI focuses on ensuring hospital infection and control practices are being conducted appropriately [6]. This includes preparing CRAs fresh on the day to ensure optimal activity and to disinfect surfaces that a soiled scrub or gown may come into contact with twice daily [45, 46]. Antimicrobial surface wiping techniques also need to be explored as mechanically removing spores by wiping surfaces has been found to be effective in reducing spore transmission [46]. Spore inactivation at varying temperatures also needs to be explored to determine optimal laundering conditions for these fabrics, as C. difficile spores have been found to survive the NHS laundering process [47]. Bacillus subtilis spores have been effectively inactivated with moist heat at >100 °C, which may be useful for C. difficile spore inactivation [44]; however, the effects of laundering on multi-use protective clothing has sparked controversy as high laundering temperatures could destroy hydrophobic PPE fabrics, reducing their ability to prevent C. difficile transmission [48].
In this study we have demonstrated that spores of different clinical C. difficile strains can survive exposure to concentrations of sodium hypochlorite. There is no significant reduction in spore viability which demonstrates that disinfection with CRAs is not effective. Previous studies have only rigorously tested Bacillus species against CRAs in vitro using bacterial kinetics; however, limited studies have sought to examine the effectiveness of CRAs against clinically relevant C. difficile spores [24–28]. This study seeks to address the gaps in the literature surrounding C. difficile -specific spore responses to CRA biocides. Therefore, it is currently unclear whether the tolerance of C. difficile spores is an observational phenomenon, or whether evolution is driving CRA tolerance at a genomic level. It is possible that factors such as temperature, exposure time and pH may affect the efficacy of CRA action, and this should be further explored to fully understand C. difficile resistance to CRAs.
Conclusion
This study highlights the ability of C. difficile spores to tolerate NaOCl disinfection at in-use recommended active chlorine concentrations. Understanding the molecular basis of these interactions is integral to practical management of CDI and reducing the burden of infection in healthcare settings. Unanswered questions remain regarding the extent of biocide tolerance within C. difficile and whether biocide tolerance is affected by antibiotic co-tolerance. Currently, this is important given that antimicrobial resistance is increasing globally. There is an urgent need to review current disinfection and infection prevention guidelines to optimize C. difficile spore disinfection practices and reduce the incidence of CDI globally.
Funding information
This work was supported by the University of Plymouth. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Acknowledgements
The authors wish to thank Plymouth Electron Microscopy Centre for their support with scanning electron microscopy studies.
Author contributions
H.A.: Formal analysis, Data Curation, Investigation, Validation, Writing – original draft Writing –review & editing. L.T.J.: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Resources, Writing – original draft, Writing – review & editing.
Conflicts of interest
The authors declare that there are no conflicts of interest.
Ethical statement
No ethical approvals were required for this research. No human work was carried out.
Footnotes
Abbreviations: CDI, C. difficile infection; c.f.u., colony forming unit; CRA, chlorine-releasing agent; LMIC, low- to middle-income country; NaDCC, sodium dichloroisocyanurate; NaOCl, Sodium hypochlorite; PPE, personal protective equipment; p.p.m., parts per million; rCDI, recurrent CDI; RT(s), Ribotype(s); SEM, scanning electron microscopy.
References
- 1.Guh AY, Mu Y, Winston LG, Johnston H, Olson D, et al. Trends in US burden of Clostridioides difficile infection and outcomes New England. J Med. 2020;382:1320–1330. doi: 10.1056/NEJMoa1910215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Czepiel J, Dróżdż M, Pituch H, Kuijper EJ, Perucki W, et al. Clostridium difficile infection: review. Eur J Clin Microbiol Infect Dis. 2019;38:1211–1221. doi: 10.1007/s10096-019-03539-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Djebbar A, Sebaihia M, Kuijper E, Harmanus C, Sanders I, et al. First molecular characterisation and PCR ribotyping of Clostridium difficile strains isolated in two Algerian Hospitals. J Infect Dev Ctries. 2018;12:015–021. doi: 10.3855/jidc.9580. [DOI] [PubMed] [Google Scholar]
- 4.Schäffler H, Breitrück A. Clostridium difficile - from colonization to infection. Front Microbiol. 2018;9:646. doi: 10.3389/fmicb.2018.00646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ashiru-Oredope D, Kerr F, Hughes S, Urch J, Lanzman M, et al. Assessing the impact of COVID-19 on antimicrobial stewardship activities/programs in the United Kingdom. Antibiotics. 2021;10:110. doi: 10.3390/antibiotics10020110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Spigaglia P. Clostridioides difficile infection (CDI) during the COVID-19 pandemic. Anaerobe. 2022;74:102518. doi: 10.1016/j.anaerobe.2022.102518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Krutova M, Wilcox M, Kuijper JE. Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view? Int J Infect Dis. 2022;124:118–123. doi: 10.1016/j.ijid.2022.09.013. [DOI] [PubMed] [Google Scholar]
- 8.Boekhoud IM, Hornung BVH, Sevilla E, Harmanus C, Bos-Sanders IMJG, et al. Plasmid-mediated metronidazole resistance in Clostridioides difficile . Nat Commun. 2020;11:598. doi: 10.1038/s41467-020-14382-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Olaitan AO, Dureja C, Youngblom MA, Topf MA, Shen W-J, et al. Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile . Nat Commun. 2023;14:4130. doi: 10.1038/s41467-023-39429-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Dureja C, Olaitan AO, Hurdle JG. Mechanisms and impact of antimicrobial resistance in Clostridioides difficile . Curr Opin Microbiol. 2022;66:63–72. doi: 10.1016/j.mib.2022.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Marchandin H, Anjou C, Poulen G, Freeman J, Wilcox M, et al. In vivo emergence of a still uncommon resistance to fidaxomicin in the urgent antimicrobial resistance threat Clostridioides difficile . J Antimicrob Chemother. 2023;78:1992–1999. doi: 10.1093/jac/dkad194. [DOI] [PubMed] [Google Scholar]
- 12.Song JH, Kim YS. Recurrent Clostridium difficile infection: risk factors, treatment, and prevention. Gut Liver. 2019;13:16–24. doi: 10.5009/gnl18071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Ellis Mulligan M, Rolfe RD, Finegold SM, George WL. Contamination of a hospital environment by Clostridium difficile . Curr Microbiol. 1979;3:173–175. doi: 10.1007/BF02601862. [DOI] [Google Scholar]
- 14.Barbut F, Petit J-C. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect. 2001;7:405–410. doi: 10.1046/j.1198-743x.2001.00289.x. [DOI] [PubMed] [Google Scholar]
- 15.Setlow P, Christie G. What’s new and notable in bacterial spore killing! World J Microbiol Biotechnol. 2021;37:144. doi: 10.1007/s11274-021-03108-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Paredes-Sabja D, Shen A, Sorg JA. Clostridium difficile spore biology: sporulation, germination, and spore structural proteins. Trends Microbiol. 2014;22:406–416. doi: 10.1016/j.tim.2014.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Driks A, Eichenberger P. The Bacterial Spore: From Molecules to Systems. Washington, DC, USA: 2016. Spore resistance properties; pp. 201–215. [DOI] [Google Scholar]
- 18.Waterfield S, Ahmed H, Jones IA, Burky R, Joshi LT. Isolation of Clostridioides difficile PCR Ribotype 027 from single-use hospital gown ties. J Med Microbiol. 2022;71:001550. doi: 10.1099/jmm.0.001550. [DOI] [PubMed] [Google Scholar]
- 19.Department of Health Clostridioides difficile infection: How to deal with the problem. 2008. [ July 26; 2023 ]. https://www.gov.uk/government/publications/clostridium-difficile-infection-how-to-deal-with-the-problem accessed.
- 20.Malyshev D, Jones IA, McKracken M, Öberg R, Harper GM, et al. Hypervirulent R20291 Clostridioides difficile spores show disinfection resilience to sodium hypochlorite despite structural changes. BMC Microbiol. 2023;23:59. doi: 10.1186/s12866-023-02787-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Joshi LT, Welsch A, Hawkins J, Baillie L. The effect of hospital biocide sodium dichloroisocyanurate on the viability and properties of Clostridium difficile spores. Lett Appl Microbiol. 2017;65:199–205. doi: 10.1111/lam.12768. [DOI] [PubMed] [Google Scholar]
- 22.Dyer C, Hutt LP, Burky R, Joshi LT. Biocide resistance and transmission of Clostridium difficile spores spiked onto clinical surfaces from an American health care facility. Appl Environ Microbiol. 2019;85:e01090-19. doi: 10.1128/AEM.01090-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Jones IA, Joshi LT. Biocide use in the antimicrobial era: a review. Molecules. 2021;26:2276. doi: 10.3390/molecules26082276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Bloomfield SF, Uso EE. The antibacterial properties of sodium hypochlorite and sodium dichloroisocyanurate as hospital disinfectants. J Hosp Infect. 1985;6:20–30. doi: 10.1016/s0195-6701(85)80014-1. [DOI] [PubMed] [Google Scholar]
- 25.Bloomfield SF, Arthur M. Effect of chlorine-releasing agents on Bacillus subtilis vegetative cells and spores. Lett Appl Microbiol. 1989;8:101–104. doi: 10.1111/j.1472-765X.1989.tb00233.x. [DOI] [Google Scholar]
- 26.Williams ND, Russell AD. The effects of some halogen-containing compounds on Bacillus subtilis endospores. J Appl Bacteriol. 1991;70:427–436. doi: 10.1111/j.1365-2672.1991.tb02960.x. [DOI] [PubMed] [Google Scholar]
- 27.Williams ND, Russell AD. The nature and site of biocide-induced sublethal injury in Bacillus subtilis spores. FEMS Microbiol Lett. 1992;78:277–280. doi: 10.1016/0378-1097(92)90040-u. [DOI] [PubMed] [Google Scholar]
- 28.Bloomfield SF, Arthur M. Interaction of Bacillus subtilis spores with sodium hypochlorite, sodium dichloroisocyanurate and chloramine-T. J Appl Bacteriol. 1992;72:166–172. doi: 10.1111/j.1365-2672.1992.tb01819.x. [DOI] [PubMed] [Google Scholar]
- 29.Dawson LF, Valiente E, Donahue EH, Birchenough G, Wren BW. Hypervirulent Clostridium difficile PCR-ribotypes exhibit resistance to widely used disinfectants. PLoS One. 2011;6:e25754. doi: 10.1371/journal.pone.0025754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Fawley WN, Underwood S, Freeman J, Baines SD, Saxton K, et al. Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. Infect Control Hosp Epidemiol. 2007;28:920–925. doi: 10.1086/519201. [DOI] [PubMed] [Google Scholar]
- 31.Sorg JA, Sonenshein AL. Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol. 2008;190:2505–2512. doi: 10.1128/JB.01765-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Miles AA, Misra SS, Irwin JO. The estimation of the bactericidal power of the blood. Epidemiol Infect. 1938;38:732–749. doi: 10.1017/S002217240001158X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Joshi LT, Phillips DS, Williams CF, Alyousef A, Baillie L. Contribution of spores to the ability of Clostridium difficile to adhere to surfaces. Appl Environ Microbiol. 2012;78:7671–7679. doi: 10.1128/AEM.01862-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Lessa FC, Winston LG, McDonald LC. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:2369–2370. doi: 10.1056/NEJMc1505190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Papp S, Kimmerl K, Gatz J, Laue M, Grunow R, et al. Evaluation of sporicidal disinfectants for the disinfection of personal protective equipment during biological hazards. Health Secur. 2020;18:36–48. doi: 10.1089/hs.2019.0128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kenters N, Huijskens EGW, de Wit SCJ, Sanders IGJM, van Rosmalen J, et al. Effectiveness of various cleaning and disinfectant products on Clostridium difficile spores of PCR ribotypes 010, 014 and 027. Antimicrob Resist Infect Control. 2017;6:54. doi: 10.1186/s13756-017-0210-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Edwards AN, Karim ST, Pascual RA, Jowhar LM, Anderson SE, et al. Chemical and stress resistances of Clostridium difficile spores and vegetative cells. Front Microbiol. 2016;7:1698. doi: 10.3389/fmicb.2016.01698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Cataño JC, Echeverri LM, Szela C. Bacterial contamination of clothes and environmental items in a third-level hospital in Colombia. Interdiscip Perspect Infect Dis. 2012;2012:507640. doi: 10.1155/2012/507640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Ilibman Arzi Y, Assous MV, Livnat K, Yinnon AM, Wiener-Well Y. Bacterial contamination of surgical scrubs in the operating theater. Am J Infect Control. 2020;48:56–60. doi: 10.1016/j.ajic.2019.06.022. [DOI] [PubMed] [Google Scholar]
- 40.Kilinc Balci FS. Isolation gowns in health care settings: laboratory studies, regulations and standards, and potential barriers of gown selection and use. Am J Infect Control. 2016;44:104–111. doi: 10.1016/j.ajic.2015.07.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Doan L, Forrest H, Fakis A, Craig J, Claxton L, et al. Clinical and cost effectiveness of eight disinfection methods for terminal disinfection of hospital isolation rooms contaminated with Clostridium difficile 027. J Hosp Infect. 2012;82:114–121. doi: 10.1016/j.jhin.2012.06.014. [DOI] [PubMed] [Google Scholar]
- 42.Blane B, Coll F, Raven K, Allen O, Kappeler ARM, et al. Impact of a new hospital with close to 100% single-occupancy rooms on environmental contamination and incidence of vancomycin-resistant Enterococcus faecium colonization or infection: a genomic surveillance study. J Hosp Infect. 2023;139:192–200. doi: 10.1016/j.jhin.2023.06.025. [DOI] [PubMed] [Google Scholar]
- 43.Scott R, Joshi LT, McGinn C. Hospital surface disinfection using ultraviolet germicidal irradiation technology: a review. Healthc Technol Lett. 2022;9:25–33. doi: 10.1049/htl2.12032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Singh M, Sharma R, Gupta PK, Rana JK, Sharma M, et al. Comparative efficacy evaluation of disinfectants routinely used in hospital practice: India. Indian J Crit Care Med. 2012;16:123–129. doi: 10.4103/0972-5229.102067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Perez J, Springthorpe VS, Sattar SA. Activity of selected oxidizing microbicides against the spores of Clostridium difficile: relevance to environmental control. Am J Infect Control. 2005;33:320–325. doi: 10.1016/j.ajic.2005.04.240. [DOI] [PubMed] [Google Scholar]
- 46.Rawlinson S, Ciric L, Cloutman-Green E. How to carry out microbiological sampling of healthcare environment surfaces? A review of current evidence. J Hosp Infect. 2019;103:363–374. doi: 10.1016/j.jhin.2019.07.015. [DOI] [PubMed] [Google Scholar]
- 47.Tarrant J, Jenkins RO, Laird KT. From ward to washer: The survival of Clostridium difficile spores on hospital bed sheets through a commercial UK NHS healthcare laundry process. Infect Control Hosp Epidemiol. 2018;39:1406–1411. doi: 10.1017/ice.2018.255. [DOI] [PubMed] [Google Scholar]
- 48.Coleman WH, Chen D, Li Y-Q, Cowan AE, Setlow P. How moist heat kills spores of Bacillus subtilis . J Bacteriol. 2007;189:8458–8466. doi: 10.1128/JB.01242-07. [DOI] [PMC free article] [PubMed] [Google Scholar]